IRIS
FERRAROTTI, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.349
AS - Asia 2.272
EU - Europa 1.693
SA - Sud America 357
Continente sconosciuto - Info sul continente non disponibili 107
AF - Africa 96
OC - Oceania 1
Totale 7.875
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.213
CN - Cina 880
SG - Singapore 545
IT - Italia 314
VN - Vietnam 306
HK - Hong Kong 288
BR - Brasile 270
IE - Irlanda 260
RU - Federazione Russa 245
DE - Germania 201
FR - Francia 131
GB - Regno Unito 125
FI - Finlandia 120
UA - Ucraina 102
CA - Canada 72
IN - India 59
ZA - Sudafrica 59
SE - Svezia 57
BD - Bangladesh 43
AR - Argentina 28
NL - Olanda 25
BE - Belgio 19
IQ - Iraq 19
PL - Polonia 18
AT - Austria 17
EC - Ecuador 17
MX - Messico 17
TR - Turchia 15
PH - Filippine 13
CZ - Repubblica Ceca 12
ES - Italia 12
ID - Indonesia 12
JP - Giappone 12
PK - Pakistan 11
VE - Venezuela 11
CO - Colombia 10
UZ - Uzbekistan 9
CL - Cile 8
MA - Marocco 8
SA - Arabia Saudita 8
CH - Svizzera 7
CR - Costa Rica 7
IL - Israele 7
JM - Giamaica 7
LT - Lituania 7
MY - Malesia 6
PY - Paraguay 6
SV - El Salvador 6
TN - Tunisia 6
DK - Danimarca 5
HN - Honduras 5
JO - Giordania 5
KE - Kenya 5
LB - Libano 5
NI - Nicaragua 5
CW - ???statistics.table.value.countryCode.CW??? 4
PE - Perù 4
PR - Porto Rico 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
ET - Etiopia 3
GT - Guatemala 3
MU - Mauritius 3
NP - Nepal 3
QA - Qatar 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BY - Bielorussia 2
DZ - Algeria 2
GP - Guadalupe 2
HU - Ungheria 2
IR - Iran 2
KR - Corea 2
KZ - Kazakistan 2
RO - Romania 2
SC - Seychelles 2
TH - Thailandia 2
AG - Antigua e Barbuda 1
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GH - Ghana 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
MM - Myanmar 1
MZ - Mozambico 1
Totale 7.764
Salva come PNG Salva come JPEG
Città #
San Jose 410
Ashburn 329
Singapore 281
Hong Kong 273
Dublin 260
Chandler 245
Dallas 218
Beijing 210
Council Bluffs 200
Nanjing 151
Jacksonville 101
Ho Chi Minh City 99
Boardman 88
Lauterbourg 84
Los Angeles 82
Ann Arbor 78
Hanoi 74
New York 65
Redondo Beach 64
Munich 61
Helsinki 60
Johannesburg 48
Lawrence 45
Medford 45
Princeton 45
Moscow 42
Nanchang 42
Dearborn 40
Shanghai 40
Santa Clara 36
São Paulo 36
Wilmington 34
Rome 32
Shenyang 32
Changsha 31
Houston 30
Buffalo 29
Milan 26
Orem 25
Phoenix 25
Toronto 24
Turku 24
Columbus 23
Jiaxing 23
Frankfurt am Main 22
Hebei 22
Brussels 19
Da Nang 19
Brooklyn 18
Pavia 18
The Dalles 18
Tianjin 18
Nuremberg 17
Vinnytsia 17
Amsterdam 15
Chicago 15
Falkenstein 15
Hangzhou 15
Montesilvano Marina 15
North Bergen 15
Woodbridge 15
Chongqing 14
London 14
Montreal 14
Naples 14
Piemonte 14
Warsaw 14
Atlanta 13
Denver 12
Haiphong 12
Tokyo 12
Kunming 11
Stockholm 11
Washington 11
Redwood City 10
Chennai 9
Turin 9
Vienna 9
Bologna 8
Guangzhou 8
Norwalk 8
Poplar 8
Tashkent 8
Ankara 7
Basingstoke 7
Des Moines 7
Jinan 7
Mumbai 7
San José 7
Seattle 7
Baghdad 6
Biên Hòa 6
Brasília 6
Charlotte 6
Düsseldorf 6
Fairfield 6
Hefei 6
Hyderabad 6
Hải Dương 6
New Delhi 6
Totale 4.855
Salva come PNG Salva come JPEG
Nome #
Immune Activation in α-1antitrypsin Deficiency Emphysema: Beyond the Protease/Antiprotease Paradigm. 219
Lyosecretome for use in the treatment of degenerative osteoarticular diseases and/or degenerative intervertebral disc disease. 161
Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration 161
Lyosecretome for use in the treatment or prevention of skin aging by inhibiting elastase and tyrosinase activity 152
Lyosecretome for use in the treatment of autoimmune diseases 152
A Pilot Study to Investigate the Balance between Proteases and α1-Antitrypsin in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients. 142
Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies 140
Lyosecretome for use in the treatment of alpha-1-antitrypsin deficiency associated diseases 133
Mesenchymal Extracellular Vesicles as Alpha-1-antitrypsin physiological delivery systems for lung regeneration 133
Expression of receptor for advanced glycation end products in sarcoid granulomas. 126
Freeze-dried MSC-secretome contains active alpha-1-antitrypsin for treatment of deficiency pulmonary diseases 125
A regulatory SNP in the Promoter Region of the RAGE Gene 123
Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels. 121
Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. 119
Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD 119
Identification and characterisation of eight novel SERPINA1 null mutations. 119
Inherited alpha1-antitrypsin deficiency: Is the level the key message? 115
Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD 114
Clinical features in patients with severe Alpha-1 antitrypsin deficiency due to rare genotypes 113
In vitro T-cell immune reactivity against promiscuous frames of hepatitis C virus core protein predicted by computational analysis 113
Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline. 113
Comparison among populations with severe and intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease 110
SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort. 109
Freeze-dried MSC-secretome for use in the treatment of alpha-1-antitrypsin deficiency pulmonary diseases 109
Alpha-1 antitrypsin deficiency: From the lung to the heart? 108
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency. 106
α₁-Antitrypsin level and pheno/genotypes 105
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications. 105
Identification of a novel alpha1-antitrypsin null variant (Q0Cairo). 102
MSC extracellular vesicles for treatment of alpha-1-antitrypsin deficiency pulmonary diseases 100
Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review 99
An Italian expert consensus on the management of alpha1-antitrypsin deficiency: a comprehensive set of algorithms 95
Clinical phenotypes of Italian and Spanish patients with α1-antitrypsin deficiency. 95
Practical dietary advices for subjects with alpha-1 antitrypsin deficiency 94
COPD: no gene left unturned 94
Molecular diagnosis of alpha1-antitrypsin deficiency: A new method based on Luminex technology 93
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 93
Improving the Laboratory Diagnosis of M-like Variants Related to Alpha1-Antitrypsin Deficiency 92
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 90
Immune Activation in alpha(1)-Antitrypsin-Deficiency Emphysema Beyond the Protease-Antiprotease Paradigm 90
In vitro T-cell immune reactivity against promiscuous frames on hepatitis C virus core proteine predicted by computational analysis 89
Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae? 89
Italian registry of patients with alpha-1 antitrypsin deficiency: General data and quality of life evaluation 88
COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale 87
The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency 87
Clinical manifestations of a new alpha-1 antitrypsin genetic variant: Q0parma 85
Comprehensive Clinical Diagnostic Pipelines Reveal New Variants in Alpha-1 Antitrypsin Deficiency 83
The pathological Trento variant of alpha-1-antitrypsin (E75V) shows nonclassical behaviour during polymerization. 80
Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer 77
Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: Enough is enough 75
Update on α1-antitrypsin deficiency 74
Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through “pharmaceuticalization” for the best formulation. 74
Comparison of different algorithms in laboratory diagnosis of alpha1-antitrypsin deficiency 73
Kruppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency. 71
Alternative transcripts of the SERPINA1 gene in alpha-1 antitrypsin deficiency 71
Real-world clinical applicability of pathogenicity predictors assessed on SERPINA1 mutations in alpha-1-antitrypsin deficiency. 71
The Genes–Stemness–Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints 70
Improving the diagnosis of AATD with aid of serum protein electrophoresis: A prospective, multicentre, validation study 68
Recommendations for the measurement of the most important plasma proteins 67
α1-Antitrypsin deficiency. 67
Place of genotyping and phenotype in addition to the assay of serum α -1 antitrypsin 65
European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency. 65
Distribution of the Clinical Manifestations of Alpha 1 Antitrypsin Deficiency in Respiratory Outpatients from an Area of Northern Italy 63
Alpha-1 antitrypsin deficiency is significantly associated with atopy in asthmatic patients 63
Sanger and Next-Generation Sequencing of AAT 62
Alpha1-antitrypsin deficiency in Greece: Focus on rare variants 62
How can we improve the detection of Alpha1-antitrypsin deficiency? 62
Clinical manifestations in patients with PI*MMMalton genotypes. A matter still unsolved in alpha-1 antitrypsin deficiency 60
Quantification of circulating alpha-1-antitrypsin polymers associated with different SERPINA1 genotypes 60
Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid. 60
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 59
Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use 56
Air Trapping Is Associated with Heterozygosity for Alpha-1 Antitrypsin Mutations in Patients with Asthma 55
Complement receptor 1 gene polymorphisms in sarcoidosis. 52
Protocol for the earco registry: A pan-european observational study in patients with α1-antitrypsin deficiency 50
Phenotypic Expression of Respiratory Diseases and Tailored Treatment in Patients with Intermediate Alpha-1 Antitrypsin Deficiency: Evidence from a Retrospective Analysis of a Selected Cohort of Patients 50
Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α1-Antitrypsin Deficiency 50
Transplant with MZ genotype liver: what is the clinical pulmonary picture after 30 years? a case report and review of the literature 49
Alpha-1 antitrypsin screening in a selected cohort of patients affected by chronic pulmonary diseases in Naples, Italy 47
SERPINA1 gene variants in individuals from the general population with reduced ?1-antitrypsin concentrations 47
Long-term effect of α1-antitrypsin augmentation therapy on the decline of fev1 in deficient patients: An analysis of the air database 45
Effect of α1 antitrypsin deficiency on lung volume decline in severe asthmatic patients undergoing biologic therapy 45
The importance of n186 in the alpha-1-antitrypsin shutter region is revealed by the novel bologna deficiency variant 43
New patient-centric approaches to the management of alpha-1 antitrypsin deficiency 43
Investigating the Link between Alpha-1 Antitrypsin Deficiency and Abdominal Aortic Aneurysms 42
What is the knowledge on alpha-1 antitrypsin deficiency among Italian pulmonologists? 41
Alpha-1 antitrypsin deficiency-associated liver disease: A review focusing on new assessment tools and therapies 41
Research priorities in α1-antitrypsin deficiency: Results of a patients’ and healthcare providers’ international survey from the earco clinical research collaboration 39
Diagnosis and treatment of pulmonarydisease in alfa-1-antitrypsin deficiency: A statement of European Respiratory Society 38
PI*ZQ0Attikon genotype discovery in severe alpha-1 antitrypsin deficiency 35
Electrophoretic α1-globulin for screening of α1-antitrypsin deficient variants 34
The phenotypic state of bi allelic SERPINA1 Q0 variants in alpha-1 antitrypsin deficiency 28
Performance of enhanced liver fibrosis test and indirect serum fibrosis markers for exclusion of advanced liver fibrosis in alpha-1 antitrypsin deficiency 14
Vasculopathy as a mechanical barrier to cancer spread: Clinical evidence and a rheology-based model in lung cancer and other solid tumors 2
Totale 7.875
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.484
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022182 0 0 0 0 1 2 5 16 13 4 28 113
2022/2023712 85 49 6 44 82 68 3 30 308 7 20 10
2023/2024395 26 75 16 10 35 98 11 20 2 53 27 22
2024/20251.476 20 71 76 90 30 134 57 80 329 70 185 334
2025/20263.159 235 200 322 348 379 158 670 118 317 231 116 65
2026/2027916 74 191 198 414 39 0 0 0 0 0 0 0
Totale 7.875